Do I need to refer a patient with a RAD (Radiology Assessment Data) TI (Tissue Imaging) 4 finding for biopsy despite the radiologist's recommendation for a 1-year follow-up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of RAD TI 4 Findings: Biopsy vs. Follow-up

For a RAD TI 4 finding, you should proceed with biopsy despite the radiologist's recommendation for 1-year follow-up, as TI-RADS 4 represents a suspicious finding that warrants tissue diagnosis. 1

Understanding TI-RADS 4 Classification

  • TI-RADS 4 (or NI-RADS 4 for neck imaging) represents a finding that is suspicious or highly suggestive of malignancy 1
  • This category reflects a high probability of malignancy that requires tissue confirmation before treatment decisions 1
  • Unlike lower categories (TI-RADS 1-3), category 4 findings have imaging characteristics that strongly suggest malignancy 1

Recommended Management Approach

When Biopsy is Necessary:

  • For BI-RADS category 4 or 5 (suspicious or highly suggestive of malignancy), tissue diagnosis using core needle biopsy (preferred) or needle localization excisional biopsy is necessary 1
  • The ACR guidelines clearly state that for suspicious findings (category 4), tissue diagnosis is required rather than observation 1
  • Even when radiologists recommend follow-up for category 4 findings, clinical practice should adhere to established guidelines requiring biopsy 2

Special Considerations:

  • While NI-RADS 4 often represents definitive known recurrence that may not require biopsy in some contexts, this applies primarily to cases where recurrence is unequivocal or when patients are enrolled in clinical trials 1
  • For initial diagnosis (rather than known recurrence), biopsy remains the standard of care for category 4 findings 1

Potential Reasons for Discordant Recommendations

  • Radiologist experience (≥20 years) may lead to less adherence to guidelines for suspicious findings 2
  • Variations in practice patterns exist, particularly for high-risk lesions 3
  • Miscommunication between radiologists and referring physicians regarding terminology and follow-up recommendations occurs frequently 4
  • Error and discrepancy rates in radiology practice are estimated at 3-5% of studies reported 5

Algorithm for Decision Making

  1. Confirm the TI-RADS 4 classification in the radiology report 1
  2. Discuss with the radiologist why they recommended follow-up despite the category 4 designation 4
  3. If no compelling reason exists to deviate from guidelines, proceed with tissue diagnosis 1
  4. Choose the appropriate biopsy method based on lesion characteristics:
    • Core needle biopsy (preferred) for most lesions 1
    • Consider image-guided biopsy for deep or difficult-to-access lesions 1
  5. Ensure pathology-imaging concordance after biopsy 1
    • If discordant, consider repeat biopsy or surgical excision 1

Important Caveats

  • Discordance between radiologist recommendations and imaging category should prompt further discussion rather than automatic acceptance of follow-up 4
  • Delaying biopsy of a suspicious finding could result in delayed diagnosis and treatment of malignancy 1
  • The risk of missing malignancy with observation alone outweighs the risks associated with biopsy for category 4 findings 6
  • Document your clinical reasoning if you choose to deviate from guidelines based on specific patient factors 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.